.svg){kind=small}
Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of California, Proof has shown a consistent presence across several categories, with notable performance in Capsules and Tincture & Sublingual products. The brand maintained a steady rank of 10th in Capsules from July to October 2024, indicating a strong foothold in this category. However, their performance in Concentrates has been more dynamic, moving from 83rd place in July to 49th by October, suggesting a significant improvement and growing market share. This upward trend in Concentrates could be an area to watch for future growth. In contrast, the Topical category saw fluctuating ranks, ending back at 11th in October, which might reflect varying consumer preferences or competitive pressures.
Proof's performance in the Tincture & Sublingual category remains robust, consistently ranking within the top 10 throughout the observed months. This stability highlights the brand's strong positioning and possibly loyal customer base in this segment. Interestingly, the absence of Proof in the top 30 brands for other categories in California might indicate areas where the brand is yet to establish a significant presence or faces stiff competition. The consistency in sales figures, particularly a notable increase in the Concentrates category, underscores Proof's potential for expansion and adaptation within the competitive landscape of California's cannabis market.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, Proof has demonstrated resilience and adaptability amidst shifting market dynamics. Over the past few months, Proof's ranking has shown some fluctuations, moving from 7th place in July 2024 to 9th in both August and September, before climbing back to 8th in October. This movement indicates a competitive struggle, particularly against brands like Friendly Farms, which consistently maintained a higher rank, and Jade Nectar, which saw an upward trend, surpassing Proof in September. Despite these challenges, Proof's sales showed a positive trend in October, suggesting a potential recovery or strategic adjustment. Meanwhile, ABX / AbsoluteXtracts maintained a stable position, indicating a steady market presence that Proof could learn from. These insights highlight the importance of strategic positioning and market adaptation for Proof to improve its standing and sales performance in this competitive category.
Notable Products
In October 2024, Proof's top-performing product was the Indica Full Spectrum Oil Syringe (1g) from the Concentrates category, maintaining its leading position from September with impressive sales of 1351 units. The CBD:THC 1:1 Bazillion Tincture Drops (1000mg CBD, 1000mg THC, 15ml) followed closely, securing the second rank, slightly improving from its third position in September. The CBD/THC 1:1 Full Spectrum Oil (1g) made a notable entry into the top three, climbing from an unranked position in September to third place in October. The CBD/THC 1:1 Balance Tincture (300mg CBD, 300mg THC, 15ml) saw a drop to fourth place, despite being second in September, indicating a shift in consumer preference within the Tincture & Sublingual category. Lastly, the THC Rich Tincture (2mg CBD, 900mg THC, 15ml) debuted at fifth place, showcasing potential for growth in future months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
